Organogenesis (ORGO) Short Interest Ratio & Short Volume $3.21 -0.17 (-5.03%) Closing price 04:00 PM EasternExtended Trading$3.33 +0.12 (+3.86%) As of 06:03 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Organogenesis Short Interest DataOrganogenesis (ORGO) has a short interest of 8.75 million shares, representing 13.41% of the float (the number of shares available for trading by the public). This marks a -16.03% decrease in short interest from the previous month. The short interest ratio (days to cover) is 12.1, indicating that it would take 12.1 days of the average trading volume of 457,601 shares to cover all short positions.Current Short Interest8,750,000 sharesPrevious Short Interest10,420,000 sharesChange Vs. Previous Month-16.03%Dollar Volume Sold Short$32.20 millionShort Interest Ratio12.1 Days to CoverLast Record DateJanuary 31, 2025Outstanding Shares125,730,000 sharesFloat Size65,240,000 sharesShort Percent of Float13.41%Today's Trading Volume266,626 sharesAverage Trading Volume457,601 sharesToday's Volume Vs. Average58% Short Selling Organogenesis? Sign up to receive the latest short interest report for Organogenesis and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartORGO Short Interest Over TimeORGO Days to Cover Over TimeORGO Percentage of Float Shorted Over Time Organogenesis Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 1/31/20258,750,000 shares $32.20 million -16.0%13.4%12.1 $3.68 1/15/202510,420,000 shares $33.66 million +0.2%16.2%14.5 $3.23 12/31/202410,400,000 shares $33.28 million -5.5%15.4%14.4 $3.20 12/15/202411,000,000 shares $37.40 million +29.1%16.3%15.9 $3.40 11/30/20248,520,000 shares $32.97 million -18.2%11.9%13 $3.87 11/15/202410,410,000 shares $40.18 million +6.3%13.7%19.6 $3.86 10/31/20249,790,000 shares $27.12 million -5.0%12.6%18.3 $2.77 10/15/202410,300,000 shares $32.96 million -1.3%13.3%18.3 $3.20 9/30/202410,440,000 shares $29.86 million -10.6%13.4%16.9 $2.86 9/15/202411,680,000 shares $32.82 million -16.5%15.0%16.1 $2.81 Get the Latest News and Ratings for ORGO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Organogenesis and its competitors with MarketBeat's FREE daily newsletter. 8/31/202413,990,000 shares $40.29 million +28.0%18.0%17.2 $2.88 8/15/202410,930,000 shares $27.54 million +10.4%14.1%11.2 $2.52 7/31/20249,900,000 shares $29.90 million +2.0%12.7%9.7 $3.02 7/15/20249,710,000 shares $28.06 million -14.3%12.5%8 $2.89 6/30/202411,330,000 shares $31.72 million +3.8%14.6%9.4 $2.80 6/15/202410,920,000 shares $27.25 million +1.8%14.0%8.9 $2.50 5/31/202410,730,000 shares $29.51 million -5.3%13.8%9.2 $2.75 5/15/202411,330,000 shares $33.65 million +16.3%14.6%10.7 $2.97 4/30/20249,740,000 shares $22.89 million +17.1%12.6%10.2 $2.35 4/15/20248,320,000 shares $22.96 million +15.1%10.8%10.7 $2.76 3/31/20247,230,000 shares $20.53 million -9.7%9.4%9.4 $2.84 3/15/20248,010,000 shares $22.83 million +5.8%10.3%11.5 $2.85 2/29/20247,570,000 shares $27.02 million +1.3%9.8%9.9 $3.57 2/15/20247,470,000 shares $27.49 million +11.3%9.4%10.2 $3.68 1/31/20246,710,000 shares $22.14 million +4.2%8.5%6.9 $3.30 1/15/20246,440,000 shares $25.24 million +56.7%8.2%6.6 $3.92 12/31/20234,110,000 shares $16.81 million -15.4%5.2%4.3 $4.09 12/15/20234,860,000 shares $18.23 million +4.1%6.2%5 $3.75 11/30/20234,670,000 shares $11.91 million -0.4%6.0%5.1 $2.55 11/15/20234,690,000 shares $11.87 million -1.7%6.0%5.4 $2.53 10/31/20234,770,000 shares $10.68 million +12.8%6.1%5 $2.24 10/15/20234,230,000 shares $9.98 million +8.2%5.4%5.1 $2.36 9/30/20233,910,000 shares $12.43 million +1.6%5.0%4.4 $3.18 9/15/20233,850,000 shares $9.43 million +25.8%4.9%4.5 $2.45 8/31/20233,060,000 shares $8.57 million +8.1%3.9%3.4 $2.80 8/15/20232,830,000 shares $7.58 million -16.5%3.6%2.8 $2.68 7/31/20233,390,000 shares $14.48 million -0.6%4.4%3.1 $4.27 7/15/20233,410,000 shares $13.30 million -7.3%5.1%3.2 $3.90 6/30/20233,680,000 shares $12.22 million -7.5%5.5%3.7 $3.32 6/15/20233,980,000 shares $16.36 million -14.0%5.9%3.8 $4.11Here’s how you could profit from Elon’s NVIDIA partnership (Ad)"Elon's #1 AI Stock" SET TO SOAR Forget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful. After all, ChatGPT just works online... While Elon's AI works in the real world. Get all the details here >>> 5/31/20234,630,000 shares $16.81 million -10.1%6.9%3.2 $3.63 5/15/20235,150,000 shares $16.38 million +0.8%7.7%3.5 $3.18 4/30/20235,110,000 shares $10.48 million +0.2%7.6%4 $2.05 4/15/20235,100,000 shares $10.56 million -1.5%7.6%4.1 $2.07 3/31/20235,180,000 shares $11.03 million -35.8%7.7%4.1 $2.13 3/15/20238,070,000 shares $17.43 million +1.3%12.1%6.5 $2.16 2/28/20237,970,000 shares $19.53 million +12.4%11.9%10 $2.45 2/15/20237,090,000 shares $20.70 million +12.2%10.2%10.7 $2.92 1/31/20236,320,000 shares $16.18 million +9.9%9.2%9.4 $2.56 1/15/20235,750,000 shares $14.89 million +2.0%8.4%9.2 $2.59 12/30/20225,640,000 shares $15.17 million +14.6%8.2%9.3 $2.69 12/15/20224,920,000 shares $12.50 million +4.9%7.8%8.1 $2.54 11/30/20224,690,000 shares $12.85 million -20.9%7.4%6.4 $2.74 11/15/20225,930,000 shares $17.02 million -0.7%9.3%6.9 $2.87 10/31/20225,970,000 shares $19.58 million +5.1%9.4%6.4 $3.28 10/15/20225,680,000 shares $18.18 million -1.1%9.0%5.7 $3.20 9/30/20225,740,000 shares $18.60 million -17.5%9.0%5.3 $3.24 9/15/20226,960,000 shares $24.78 million +7.4%11.0%5.9 $3.56 8/31/20226,480,000 shares $23.26 million +4.5%10.4%5.8 $3.59 8/15/20226,200,000 shares $30.19 million -16.9%9.9%5.8 $4.87 7/31/20227,460,000 shares $42.82 million +2.1%12.1%6.8 $5.74 7/15/20227,310,000 shares $38.52 million +6.7%11.8%6.8 $5.27 6/30/20226,850,000 shares $33.43 million -3.3%11.1%6.3 $4.88 6/15/20227,080,000 shares $36.75 million -2.5%11.4%6.8 $5.19 5/31/20227,260,000 shares $40.73 million -12.6%11.7%6.7 $5.61 5/15/20228,310,000 shares $51.27 million -13.4%13.4%7.2 $6.17 4/30/20229,600,000 shares $61.82 million +9.2%15.6%8.6 $6.44 4/15/20228,790,000 shares $64.61 million +10.7%14.2%8.1 $7.35 3/31/20227,940,000 shares $60.50 million -5.4%12.9%7.4 $7.62 3/15/20228,390,000 shares $62.51 million -10.9%13.6%8.1 $7.45 2/28/20229,420,000 shares $70.08 million -8.5%15.3%9.5 $7.44 2/15/202210,300,000 shares $82.71 million +24.7%16.5%11.4 $8.03 1/31/20228,260,000 shares $63.52 million +0.9%17.8%9.7 $7.69 1/15/20228,190,000 shares $68.96 million -4.4%15.0%9.8 $8.42 12/31/20218,570,000 shares $79.19 million +15.8%15.7%8.9 $9.24 12/15/20217,400,000 shares $67.41 million +0.4%13.4%7 $9.11 11/30/20217,370,000 shares $74.14 million -1.7%13.3%6.6 $10.06 11/15/20217,500,000 shares $81 million -18.0%11.9%6.6 $10.80 10/29/20219,150,000 shares $100.47 million +17.0%14.6%8.3 $10.98 10/15/20217,820,000 shares $85.63 million +28.2%12.4%7.3 $10.95 9/30/20216,100,000 shares $59.54 million +4.5%9.8%6.6 $9.76 9/15/20215,840,000 shares $90.46 million -6.0%9.3%6.1 $15.49 8/31/20216,210,000 shares $105.94 million -4.9%9.9%6.4 $17.06 8/13/20216,530,000 shares $98.54 million -2.4%10.5%4.9 $15.09 7/30/20216,690,000 shares $102.62 million +3.1%10.8%4.8 $15.34 7/15/20216,490,000 shares $102.35 million +0.3%10.4%4.8 $15.77 6/30/20216,470,000 shares $107.53 million +70.7%10.3%4.9 $16.62 6/15/20213,790,000 shares $59.84 million +14.2%6.0%2.9 $15.79 5/28/20213,320,000 shares $59.20 million +32.8%5.3%2.9 $17.83 5/14/20212,500,000 shares $44.48 million +12.1%3.8%3.2 $17.79Here’s how you could profit from Elon’s NVIDIA partnership (Ad)"Elon's #1 AI Stock" SET TO SOAR Forget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful. After all, ChatGPT just works online... While Elon's AI works in the real world. Get all the details here >>> 4/30/20212,230,000 shares $47.52 million -3.0%7.9%2.9 $21.31 4/15/20212,300,000 shares $50.37 million +24.3%8.1%3 $21.90 3/31/20211,850,000 shares $33.61 million -15.5%7.1%2.1 $18.17 3/15/20212,190,000 shares $38.81 million +273.2%8.4%2.6 $17.72 2/26/2021586,900 shares $8.51 million -43.6%2.3%0.7 $14.51 2/12/20211,040,000 shares $14.25 million +1.0%4.1%1.4 $13.70 1/29/20211,030,000 shares $10.60 million +5.0%3.9%1.4 $10.29 1/15/2021980,800 shares $9.31 million -10.8%3.7%1.4 $9.49 12/31/20201,100,000 shares $8.20 million +243.6%4.1%2.1 $7.45 12/15/2020320,100 shares $1.63 million +4.7%1.2%0.7 $5.10 11/30/2020305,800 shares $1.53 million -39.8%1.2%0.9 $4.99 11/15/2020508,300 shares $2.15 million +41.4%6.0%1.8 $4.22 10/30/2020359,400 shares $1.31 million -12.0%2.8%2.3 $3.65 10/15/2020408,200 shares $1.54 million +1.0%3.7%2.7 $3.78 9/30/2020404,200 shares $1.55 million +7.8%3.7%4.1 $3.84 9/15/2020374,900 shares $1.54 million +2.9%3.4%3.1 $4.11 8/31/2020364,500 shares $1.57 million -3.1%3.3%2.7 $4.30 8/14/2020376,000 shares $1.53 million -6.9%3.3%1.7 $4.08 7/31/2020403,800 shares $1.49 million +5.0%3.5%1.8 $3.68 7/15/2020384,500 shares $1.48 million -19.0%3.3%1.8 $3.84 6/30/2020474,400 shares $1.82 million +94.2%4.1%2.6 $3.84 6/15/2020244,300 shares $938,112.00 -31.1%2.1%1.5 $3.84 5/29/2020354,700 shares $1.64 million +22.4%3.2%2 $4.61 5/15/2020289,800 shares $901,278.00 -4.1%2.6%2.9 $3.11 4/30/2020302,100 shares $1.12 million -8.6%2.8%3.6 $3.71 4/15/2020330,500 shares $1.01 million +9.2%2.8%4.1 $3.07 3/31/2020302,700 shares $1.11 million +78.8%2.6%3.5 $3.67 3/13/2020169,300 shares $560,383.00 +43.7%1.6%0.9 $3.31 2/28/2020117,800 shares $343,976.00 +55.0%1.1%1.4 $2.92 ORGO Short Interest - Frequently Asked Questions What is Organogenesis' current short interest? Short interest is the volume of Organogenesis shares that have been sold short but have not yet been covered or closed out. As of January 31st, traders have sold 8,750,000 shares of ORGO short. 13.41% of Organogenesis' shares are currently sold short. Learn More on Organogenesis' current short interest. What is a good short interest ratio for Organogenesis? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ORGO shares currently have a short interest ratio of 12.0. Learn More on Organogenesis's short interest ratio. Which institutional investors are shorting Organogenesis? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Organogenesis: Citadel Advisors LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Organogenesis? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 13.41% of Organogenesis' floating shares are currently sold short. Is Organogenesis' short interest increasing or decreasing? Organogenesis saw a drop in short interest in the month of January. As of January 31st, there was short interest totaling 8,750,000 shares, a drop of 16.0% from the previous total of 10,420,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Organogenesis' float size? Organogenesis currently has issued a total of 125,730,000 shares. Some of Organogenesis' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Organogenesis currently has a public float of 65,240,000 shares. How does Organogenesis' short interest compare to its competitors? 13.41% of Organogenesis' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Organogenesis: NewAmsterdam Pharma (4.62%), Apogee Therapeutics, Inc. (24.33%), Belite Bio, Inc (0.20%), Travere Therapeutics, Inc. (12.25%), Disc Medicine, Inc. (12.11%), Wave Life Sciences Ltd. (6.16%), Iovance Biotherapeutics, Inc. (26.04%), Evotec SE (0.22%), Praxis Precision Medicines, Inc. (15.21%), Amphastar Pharmaceuticals, Inc. (11.54%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.21 billion), Charter Communications, Inc. ($4.07 billion), Reddit, Inc. ($3.33 billion), The Kroger Co. ($2.67 billion), Cencora, Inc. ($2.29 billion), Hims & Hers Health, Inc. ($2.17 billion), SoFi Technologies, Inc. ($1.99 billion), Live Nation Entertainment, Inc. ($1.87 billion), Rivian Automotive, Inc. ($1.76 billion), and Moderna, Inc. ($1.60 billion). View all of the most shorted stocks. What does it mean to sell short Organogenesis stock? Short selling ORGO is an investing strategy that aims to generate trading profit from Organogenesis as its price is falling. ORGO shares are trading down $0.17 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Organogenesis? A short squeeze for Organogenesis occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ORGO, which in turn drives the price of the stock up even further. How often is Organogenesis' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ORGO, twice per month. The most recent reporting period available is January, 31 2025. More Short Interest Resources from MarketBeat Related Companies NAMS Short Interest Data APGE Short Interest Data BLTE Short Interest Data TVTX Short Interest Data IRON Short Interest Data WVE Short Interest Data IOVA Short Interest Data EVO Short Interest Data PRAX Short Interest Data AMPH Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ORGO) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | SponsoredTop Picks for Trump’s Pro-Crypto America10,000% Crypto Opportunities in 2025 27 of the brightest minds in crypto share exclusive intel… Crypto 101 Media | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Organogenesis Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Organogenesis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
